Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 89376

1.

Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced Antibodies.

Asati A, Kachurina O, Karol A, Dhir V, Nguyen M, Parkhill R, Kouiavskaia D, Chumakov K, Warren W, Kachurin A.

PLoS One. 2016 Feb 10;11(2):e0144261. doi: 10.1371/journal.pone.0144261. eCollection 2016.

PMID:
26863313
2.

Self-assembling protein nanoparticles in the design of vaccines.

López-Sagaseta J, Malito E, Rappuoli R, Bottomley MJ.

Comput Struct Biotechnol J. 2015 Nov 26;14:58-68. doi: 10.1016/j.csbj.2015.11.001. eCollection 2016. Review.

PMID:
26862374
3.

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.

Bol KF, Aarntzen EH, Pots JM, Olde Nordkamp MA, van de Rakt MW, Scharenborg NM, de Boer AJ, van Oorschot TG, Croockewit SA, Blokx WA, Oyen WJ, Boerman OC, Mus RD, van Rossum MM, van der Graaf CA, Punt CJ, Adema GJ, Figdor CG, de Vries IJ, Schreibelt G.

Cancer Immunol Immunother. 2016 Feb 10. [Epub ahead of print]

PMID:
26861670
4.

Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.

Fernandez-Garcia MD, Meertens L, Chazal M, Hafirassou ML, Dejarnac O, Zamborlini A, Despres P, Sauvonnet N, Arenzana-Seisdedos F, Jouvenet N, Amara A.

MBio. 2016 Feb 9;7(1). pii: e01956-15. doi: 10.1128/mBio.01956-15.

PMID:
26861019
5.

In situ vaccination for the treatment of cancer.

Hammerich L, Bhardwaj N, Kohrt HE, Brody JD.

Immunotherapy. 2016 Feb 9. [Epub ahead of print]

PMID:
26860335
6.

Mucosal vaccine delivery: Current state and a pediatric perspective.

Shakya AK, Chowdhury MY, Tao W, Gill HS.

J Control Release. 2016 Feb 6. pii: S0168-3659(16)30067-0. doi: 10.1016/j.jconrel.2016.02.014. [Epub ahead of print]

PMID:
26860287
7.

Surveillance of Canine Rabies in the Central African Republic: Impact on Human Health and Molecular Epidemiology.

Tricou V, Bouscaillou J, Kamba Mebourou E, Koyanongo FD, Nakouné E, Kazanji M.

PLoS Negl Trop Dis. 2016 Feb 9;10(2):e0004433. doi: 10.1371/journal.pntd.0004433. eCollection 2016 Feb.

PMID:
26859829
8.

Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.

Perronne C, Adjagba A, Duclos P, Floret D, Houweling H, Le Goaster C, Lévy-Brühl D, Meyer F, Senouci K, Wichmann O.

Vaccine. 2016 Feb 6. pii: S0264-410X(16)00126-2. doi: 10.1016/j.vaccine.2016.01.063. [Epub ahead of print]

PMID:
26859237
9.

Development of a Sterne-Based Complement Fixation Test to Monitor the Humoral Response Induced by Anthrax Vaccines.

Adone R, Sali M, Francia M, Iatarola M, Donatiello A, Fasanella A.

Front Microbiol. 2016 Jan 28;7:19. doi: 10.3389/fmicb.2016.00019. eCollection 2016.

PMID:
26858700
10.

Since The Start Of The Vaccines For Children Program, Uptake Has Increased, And Most Disparities Have Decreased.

Walsh B, Doherty E, O'Neill C.

Health Aff (Millwood). 2016 Feb 1;35(2):356-64. doi: 10.1377/hlthaff.2015.1019.

PMID:
26858392
11.

Exploring The Impact Of The US Measles Outbreak On Parental Awareness Of And Support For Vaccination.

Cacciatore MA, Nowak G, Evans NJ.

Health Aff (Millwood). 2016 Feb 1;35(2):334-40. doi: 10.1377/hlthaff.2015.1093.

PMID:
26858389
12.

Argentina's Successful Implementation Of A National Human Papillomavirus Vaccination Program.

Patel H, Wilson E, Vizzotti C, Parston G, Prestt J, Darzi A.

Health Aff (Millwood). 2016 Feb 1;35(2):301-8. doi: 10.1377/hlthaff.2015.1416.

PMID:
26858384
13.

Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction.

Shen AK, Weiss JM, Andrus JK, Pecenka C, Atherly D, Taylor K, McQuestion M.

Health Aff (Millwood). 2016 Feb 1;35(2):272-6. doi: 10.1377/hlthaff.2015.1418.

PMID:
26858380
14.

Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.

Haakenstad A, Birger M, Singh L, Liu P, Lim S, Ng M, Dieleman JL.

Health Aff (Millwood). 2016 Feb 1;35(2):242-9. doi: 10.1377/hlthaff.2015.1080.

PMID:
26858376
15.

The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness.

Luyten J, Beutels P.

Health Aff (Millwood). 2016 Feb 1;35(2):212-8. doi: 10.1377/hlthaff.2015.1088.

PMID:
26858372
16.

When Not All That Counts Can Be Counted: Economic Evaluations And The Value Of Vaccination.

Schwartz JL, Mahmoud A.

Health Aff (Millwood). 2016 Feb 1;35(2):208-11. doi: 10.1377/hlthaff.2015.1438.

PMID:
26858371
17.

Ebola vaccine development plan: ethics, concerns and proposed measures.

Folayan MO, Yakubu A, Haire B, Peterson K.

BMC Med Ethics. 2016 Feb 8;17(1):10. doi: 10.1186/s12910-016-0094-4.

PMID:
26857351
18.

Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.

Herweijer E, Sundström K, Ploner A, Uhnoo I, Sparén P, Arnheim-Dahlström L.

Int J Cancer. 2016 Feb 9. doi: 10.1002/ijc.30035. [Epub ahead of print]

PMID:
26856527
19.

The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.

Williams BA, Kidane T, Chirwa G, Tesfaye N, Prescott MR, Scotney ST, Valle M, Abebe S, Tambuli A, Malewezi B, Mohammed T, Kobayashi E, Wootton E, Wong R, Dosani R, Subramaniam H, Joseph J, Yavuz E, Apple A, Le Tallec Y, Kang'ethe A.

Health Policy Plan. 2016 Feb 7. pii: czv103. [Epub ahead of print]

PMID:
26856361
20.

A Live Vector Expressing HPV16 L1 Generates an Adjuvant-Induced Antibody Response In-vivo.

Shirbaghaee Z, Bolhassani A, Mirshafiey A, Motevalli F, Zohrei N.

Iran J Cancer Prev. 2015 Dec;8(6):e3991. doi: 10.17795/ijcp-3991. Epub 2015 Dec 23.

PMID:
26855722
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk